Myanma Pharmaceutical Industry Enterprise
From Wikipedia, the free encyclopedia
| မြန်မာ့ဆေးဝါးလုပ်ငန်း | |
| Agency overview | |
|---|---|
| Formed | 1957 |
| Parent agency | Ministry of Industry |
Myanma Pharmaceutical Industrial Enterprise (MPIE; Burmese: မြန်မာ့ဆေးဝါးလုပ်ငန်း) is a state-owned enterprise (SOE) under the Ministry of Industry that conducts R&D, manufacturing and distribution for over 200 essential pharmaceuticals.[1]
MPIE has a domestic market share ranging between 3% and 10%.[2] MPIE also exports antivenom drugs to neighboring Cambodia and Laos.[3] In 2016, MPIE produced over 800 million tablets and capsules, and has launched new product lines including vaccinations and antibiotics, in recent years.[4] MPIE also supplies drugs to other government agencies, including the Ministry of Defence, and the Ministry of Health and Sports.[4]
During the socialist era, Burma had a single registered drug producer, the Burma Pharmaceutical Industry (BPI), whose brand had a solid reputation among domestic consumers.[5] It was renamed the Myanmar Pharmaceutical Factory (MPF) in 1988.[6] MPIE continues to use the BPI trademark, because the brand name remains reputable and highly recognized domestically.[2]
Operations
MPIE operates 3 state-owned pharmaceutical factories throughout Myanmar:
- Insein, Yangon Region[7]
- Inyaung, Kyaukse Township, Mandalay Region[8]
- Ywathagyi, Hlegu Township, Yangon Region[9]